update Updates

DePuy Announces It Will Stop Selling Metal-On-Metal Hip Implants

Johnson & Johnson subsidiary DePuy Orthopaedics announced on May 16 that it will stop sales of metal-on-metal hip replacements. This comes after the company saw the market for the products drop significantly amid lawsuits and calls for increased regulation and after the 2010 recall of the DePuy ASR hip implant. Johnson… Read more

DePuy Moves to Exclude Evidence of DePuy ASR Recall in Federal Trial

As pretrial proceedings progress in the first bellwether DePuy ASR hip trial in federal court RLG an ASR law firm reports that Johnson & Johnson subsidiary DePuy has motioned to exclude evidence of the recalls of the ASR and other DePuy products. The firm provides more information on the ASR metal-on-metal hip… Read more

DePuy to Market New Hip Implant, Rottenstein Law Group Reports

As the company faces thousands of DePuy ASR lawsuits across the nation Johnson & Johnson subsidiary DePuy received FDA approval of its premarket approval application supplement in April 2013 for a ceramic-on-ceramic total hip replacement system. The Rottenstein Law Group a DePuy ASR law firm notes that this all-ceramic system differs from… Read more

Rottenstein Law Group Encouraged by Medical Device Safety Reporting App

The U.S. Food and Drug Administration has authorized a smartphone app for doctors to more easily report safety issues with high-risk medical devices such as metal-on-metal hip replacements according to the Wall Street Journal. RLG maintains a Hip Replacement Lawsuit Center that offers information on hip implants and filing a hip lawsuit and represents clients in… Read more

RLG Applauds Consumers Union Metal-on-Metal Hips Letter to FDA

The Consumers Union the organization that publishes Consumer Reports sent the U.S. Food and Drug Administration a letter this month asking the FDA to ensure that metal-on-metal hips and surgical mesh undergo the FDA’s most stringent review processes. RLG noting that the letter was backed by the signatures of 11 000 people … Read more

RLG Anticipates Verdict in 2nd DePuy Hip Trial

The jury in the nation’s second DePuy ASR trial is expected to deliberate next week in Chicago to determine if Johnson & Johnson and its subsidiary DePuy must pay plaintiff Carol Strum damages for injuries she allegedly suffered from her DePuy ASR metal-on-metal hip implant according to court documents (In Re DePuy ASR Hip… Read more

Second DePuy ASR Trial Begins

A new DePuy ASR metal-on-metal hip replacement trial was scheduled to begin this week in Illinois state court in Chicago according to court records. Carol Strum a 54-year-old nurse from Illinois alleges that Johnson & Johnson failed to warn of the risks associated with the device’s defective design. This… Read more

RLG Encouraged By $8.34 Million Verdict in California

On Friday March 8 jurors in the first DePuy ASR hip replacement trial in the nation awarded plaintiff Loren Kransky 65 $8.34 million in damages but declined to assess punitive damages against DePuy and its parent company Johnson & Johnson according to a Bloomberg report. RLG which files DePuy… Read more

Plaintiff’s Attorney Alleges J&J Pursued Profits Over Safety; Asks for as Much as $180 Million in Damages

As the jury deliberates over a verdict in the nation’s first DePuy ASR hip lawsuit to go to trial—of potentially thousands—the Rottenstein Law Group responds to the plaintiff’s attorney’s assertion during closing arguments that Johnson & Johnson subsidiary DePuy Orthopaedics knew the recalled ASR hip replacement implant was defective but continued to sell the device. … Read more

J&J Expert Alleges Plaintiff’s Pre-existing Conditions—Not the ASR Hip Implant—Caused Metal Poisoning

As the nation’s first DePuy ASR trial—of potentially thousands—nears its end an expert for Johnson & Johnson the company whose subsidiary made the now-recalled ASR metal-on-metal hip replacement system testified that it was the plaintiff’s various health problems and not his since-removed ASR hip implant that caused him metal poisoning and infection…. Read more

RLG Responds to Another Johnson & Johnson Metal-on-Metal Hip Implant Recall

Last month Johnson & Johnson initiated another DePuy recall this time centered on its Adept line of metal-on-metal hip replacement components according to a Feb. 14 Reuters report. This is the second such device Johnson & Johnson has withdrawn from the market the other being the DePuy ASR which it recalled in… Read more

RLG Comments on News That J&J Marketing Department Was Concerned DePuy ASR Side Effects Would Affect Sales

More testimony during the DePuy ASR trial points toward potential problems for Johnson & Johnson. The company’s marketing department allegedly encouraged its sales staff in emails and at a conference to be “ruthless” about selling the later-recalled DePuy ASR hip replacement system RLG reports after reviewing videotaped testimony given on Feb. 13 at the trial… Read more

RLG encourages you to reproduce our original content—on your own web site; in emails to your friends and family; in blogs, posts, and tweets, etc.—but we ask that you please attribute whatever you use to us, and, whenever possible, provide a link to the page where you first found the material. That way, whoever reads your excerpt might read more informative material of interest at one of RLG's sites.
You’ve taken enough. We'll take it from here. Click here to contact us now.